Source · HSSIB Patient Safety Investigation
The prescribing of lithium for bipolar disorder
Launched 4 November 2025
Launched
Mental health
Medication
Around 1 in 50 adults experience bipolar disorder within their lives. Whilst the number of people with bipolar disorder has remained consistent over time the prescribing of lithium has been in decline for decades. There is concern about the decline of lithium prescribing due to it's effectiveness as a treatment for bipolar disorder.
No items extracted
No safety recommendations, observations, actions, learning prompts, scope items, or areas of improvement were extracted from this investigation.
This may be a launched investigation with no published scope bullets yet, or a thematic review without extractable formal items.